SCHEMBL29120909

SCHEMBL29120909

C=C(C)C(=O)C(CC(C)C)OC(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.37
LMNA P02545 2/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
LAP3 P28838 2/20 0.33
CACNA2D1 P54289 2/20 0.32
CACNB3 P54284 1/20 0.32
CACNA1C Q13936 1/20 0.32
PGR P06401 1/20 0.32
ADRA1A P35348 1/20 0.32
HTR2B P41595 1/20 0.32
CACNA2D2 Q9NY47 1/20 0.32
SLC7A5 Q01650 1/20 0.32
FOLH1 Q04609 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29120919 1.00 TSHR (0.37) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL29120908 1.00 TSHR (0.37) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL29120907 0.75 FOLH1 (0.35) TSHRFOLH1
SCHEMBL29100176 0.75 LMNA (0.39) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL22501355 0.75 LMNA (0.39) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL22501356 0.75 LMNA (0.39) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL8155376 0.74 TDP1 (0.42) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL225530 0.71 TSHR (0.58) TSHRLMNACHRM2CHRM4CHRM5
SCHEMBL17943255 0.70 SLC7A5 (0.54) TSHRTDP1LAP3CACNA2D1CACNB3
SCHEMBL8088103 0.70 SLC7A5 (0.54) TSHRTDP1LAP3CACNA2D1CACNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641863-B Intermediate for synthesizing carfilzomib and synthesis of pharmaceutically acceptable salt thereof 美国安进公司 2023-10-20 CN disclosed